Prescription GLP-1 receptor agonists such as semaglutide and tirzepatide have undergone extensive clinical trials and received FDA approval for specific indications
Tracker type Pipeline Theme This page answers a focused pipeline question and connects it to the compounds, timelines, and comparisons that matter most
From what we know now, it would significantly raise the cost of coverage for our employer groups and our members, says Matt Burns, chief actuary at Blue Cross and Blue Shield of Kansas
L-carnitine supplementation has been shown to help attenuate exercise-induced muscle damage and to support resistance to muscle soreness and stiffness, which often occurs in the days after intense exercise
FDA staff also said that the evaluation criteria weigh against placing KPV on the list
The trials were registered at ClinicalTrials.gov (trial identifiers: NCT01037582 and NCT01686945, respectively)